Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy—EORTC Infectious Diseases Group Trial XV

Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies

(2010) Marcelo Bellesso et al.   ANNALS OF HEMATOLOGY

Management of febrile neutropenia: ESMO Clinical Practice Guidelines

(2010) J. de Naurois et al.   ANNALS OF ONCOLOGY

Predicting Adverse Events in Children With Fever and Chemotherapy-Induced Neutropenia: The Prospective Multicenter SPOG 2003 FN Study

(2010) Roland A. Ammann et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of direct medical costs of hospitalization for febrile neutropenia

(2009) Nina Lathia et al.   CANCER

Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin

(2009) Françoise Van Bambeke et al.   DRUG SAFETY

The Newer Fluoroquinolones

(2009) Maureen K. Bolon   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Risk Prediction in Pediatric Cancer Patients With Fever and Neutropenia

(2009) Hana Hakim et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients

(2009) Kenneth V. I. Rolston et al.   SUPPORTIVE CARE IN CANCER

Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients

(2008) Nirmala Devi Baskaran et al.   ANNALS OF HEMATOLOGY

Prevalence and Risk Factors for Selection of Quinolone-Resistant Escherichia coli Strains in Fecal Flora of Patients Receiving Quinolone Therapy

(2008) D. Yagci et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution

(2008) C. Cattaneo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia

(2008) Linda S. Elting et al.   JOURNAL OF CLINICAL ONCOLOGY

Trimethoprim/Sulfamethoxazole Resistance in Urinary Tract Infections

(2008) Ozlem Guneysel et al.   JOURNAL OF EMERGENCY MEDICINE

Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

(2008) Catherine Sebban et al.   SUPPORTIVE CARE IN CANCER